Hantz Financial Services, Inc. Amgen Inc Transaction History

Hantz Financial Services, Inc.

$5.63 Billion
Q3 2024

A detailed history of Hantz Financial Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 1,060 shares of AMGN stock, worth $307,294. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,060

Previous 1,098 3.46%

Holding current value

$307,294

Previous $343,000 0.29%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $11,756 - $12,820	-38 Reduced 3.46%	1,060 $342,000
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $288,499 - $350,602	1,098 New	1,098 $343,000
Q1 2024 Aug 06, 2024	BUY	$268.87 - $324.56 $7,528 - $9,087	28 Added 2.74%	1,051 $299,000
Q4 2023 Aug 06, 2024	SELL	$255.7 - $288.46 $36,565 - $41,249	-143 Reduced 12.26%	1,023 $295,000
Q3 2023 Aug 06, 2024	BUY	$218.65 - $271.46 $26,019 - $32,303	119 Added 11.37%	1,166 $313,000
Q2 2023 Aug 06, 2024	SELL	$214.27 - $253.37 $36,425 - $43,072	-170 Reduced 13.97%	1,047 $232,000
Q1 2023 Aug 06, 2024	BUY	$225.79 - $275.2 $59,608 - $72,652	264 Added 27.7%	1,217 $294,000
Q4 2022 Aug 06, 2024	SELL	$229.03 - $291.01 $2,748 - $3,492	-12 Reduced 1.24%	953 $250,000
Q3 2022 Aug 06, 2024	SELL	$224.46 - $253.15 $13,243 - $14,935	-59 Reduced 5.76%	965 $217,000
Q2 2022 Aug 06, 2024	SELL	$230.71 - $256.74 $10,612 - $11,810	-46 Reduced 4.3%	1,024 $249,000
Q1 2022 Aug 06, 2024	SELL	$219.27 - $242.57 $31,574 - $34,930	-144 Reduced 11.86%	1,070 $259,000
Q4 2021 Aug 06, 2024	SELL	$198.88 - $227.6 $3,182 - $3,641	-16 Reduced 1.3%	1,214 $273,000
Q3 2021 Aug 06, 2024	SELL	$212.27 - $248.7 $1.44 Million - $1.69 Million	-6,783 Reduced 84.65%	1,230 $262,000
Q2 2021 Aug 06, 2024	BUY	$233.58 - $259.14 $33,635 - $37,316	144 Added 1.83%	8,013 $1.95 Million
Q1 2021 Aug 06, 2024	BUY	$221.91 - $258.6 $1.5 Million - $1.75 Million	6,771 Added 616.67%	7,869 $1.96 Million
Q4 2020 Aug 06, 2024	BUY	$216.38 - $257.67 $125,933 - $149,963	582 Added 2.97%	20,179 $4.64 Million
Q3 2020 Aug 06, 2024	BUY	$234.65 - $260.95 $126,007 - $140,130	537 Added 2.82%	19,597 $4.98 Million
Q2 2020 Aug 06, 2024	BUY	$197.81 - $242.74 $429,841 - $527,474	2,173 Added 12.87%	19,060 $4.5 Million
Q1 2020 Aug 06, 2024	BUY	$182.24 - $241.7 $2.88 Million - $3.82 Million	15,789 Added 1437.98%	16,887 $3.42 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Account

Hantz Financial Services, Inc. Amgen Inc Transaction History